Innospec Inc. (NASDAQ:IOSP) CFO Ian Cleminson sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $71.67, for a total value of $358,350.00. Following the transaction, the chief financial officer now directly owns 22,997 shares of the company’s stock, valued at approximately $1,648,194.99. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Ian Cleminson also recently made the following trade(s):

  • On Tuesday, November 28th, Ian Cleminson sold 515 shares of Innospec stock. The shares were sold at an average price of $71.56, for a total value of $36,853.40.

Innospec Inc. (NASDAQ:IOSP) opened at $70.75 on Wednesday. Innospec Inc. has a 52-week low of $54.10 and a 52-week high of $74.75. The stock has a market capitalization of $1,733.08, a P/E ratio of 16.89 and a beta of 1.20. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.24 and a quick ratio of 1.35.

Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, November 7th. The specialty chemicals company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.15. Innospec had a return on equity of 15.05% and a net margin of 7.45%. The firm had revenue of $332.40 million during the quarter, compared to analyst estimates of $309.40 million. During the same quarter in the prior year, the company earned $0.78 EPS. The business’s revenue was up 61.8% compared to the same quarter last year. research analysts expect that Innospec Inc. will post 4.3 earnings per share for the current fiscal year.

The company also recently announced a semiannual dividend, which was paid on Monday, November 27th. Stockholders of record on Thursday, November 16th were given a $0.39 dividend. The ex-dividend date was Wednesday, November 15th. This represents a dividend yield of 1.12%. This is a positive change from Innospec’s previous semiannual dividend of $0.38. Innospec’s dividend payout ratio is currently 21.61%.

Several large investors have recently made changes to their positions in IOSP. Aperio Group LLC raised its position in shares of Innospec by 12.6% in the 2nd quarter. Aperio Group LLC now owns 7,279 shares of the specialty chemicals company’s stock worth $477,000 after acquiring an additional 814 shares in the last quarter. Strs Ohio raised its position in shares of Innospec by 6.3% in the 2nd quarter. Strs Ohio now owns 13,600 shares of the specialty chemicals company’s stock worth $891,000 after acquiring an additional 800 shares in the last quarter. Great West Life Assurance Co. Can raised its position in shares of Innospec by 3.0% in the 2nd quarter. Great West Life Assurance Co. Can now owns 35,015 shares of the specialty chemicals company’s stock worth $2,293,000 after acquiring an additional 1,020 shares in the last quarter. Texas Permanent School Fund raised its position in shares of Innospec by 1.1% in the 2nd quarter. Texas Permanent School Fund now owns 17,618 shares of the specialty chemicals company’s stock worth $1,155,000 after acquiring an additional 190 shares in the last quarter. Finally, Sei Investments Co. raised its position in shares of Innospec by 100.1% in the 2nd quarter. Sei Investments Co. now owns 36,827 shares of the specialty chemicals company’s stock worth $2,414,000 after acquiring an additional 18,420 shares in the last quarter. 91.20% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts have commented on the company. Johnson Rice raised Innospec from a “hold” rating to an “accumulate” rating in a research report on Tuesday, November 14th. Zacks Investment Research raised Innospec from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a research report on Friday, November 10th. Monness Crespi & Hardt lowered Innospec from a “buy” rating to a “neutral” rating in a research report on Thursday, November 9th. KeyCorp reaffirmed an “overweight” rating on shares of Innospec in a research report on Thursday, November 9th. Finally, ValuEngine raised Innospec from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $70.50.

WARNING: “Ian Cleminson Sells 5,000 Shares of Innospec Inc. (IOSP) Stock” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/12/06/ian-cleminson-sells-5000-shares-of-innospec-inc-iosp-stock.html.

About Innospec

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Stock Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related stocks with our FREE daily email newsletter.